FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fadia T. Shaya

Research Profile

Geographic Areas

Activities & Behaviors

Living Beings

Concepts & Ideas

Procedures

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Fadia T. Shaya; Xia Yan; Morgan Bron; Viktor V Chirikov; Clyde Foster; DeLeonardo Howard; Niharika Khanna; Verlyn O Warrington
Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy.
Fadia T. Shaya; Jon Shematek; Viktor V Chirikov; C. Daniel Mullins; Clyde Foster; Deleonardo Howard; Elijah Saunders
Social networks help control hypertension.
Ian M Breunig; Fadia T. Shaya; Steven M Scharf
Delivering cost-effective care for COPD in the USA: recent progress and current challenges.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fadia T. Shaya (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fadia T. Shaya; Xia Yan; Morgan Bron; Viktor V Chirikov; Clyde Foster; DeLeonardo Howard; Niharika Khanna; Verlyn O Warrington
Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy.
Expert review of pharmacoeconomics & outcomes research 2013;13(1):153-60.
2013: Fadia T. Shaya; Jon Shematek; Viktor V Chirikov; C. Daniel Mullins; Clyde Foster; Deleonardo Howard; Elijah Saunders
Social networks help control hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(1):34-40.
2012: Ian M Breunig; Fadia T. Shaya; Steven M Scharf
Delivering cost-effective care for COPD in the USA: recent progress and current challenges.
Expert review of pharmacoeconomics & outcomes research 2012;12(6):725-31.
2012: Fadia T. Shaya; Ian M Breunig; Steven M Scharf
The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong.
Expert review of pharmacoeconomics & outcomes research 2012;12(1):19-21.
2012: C. Daniel Mullins; Lisa Blatt; Fadia T. Shaya; Elijah Saunders
A qualitative evaluation of a citywide Community Health Partnership program.
Journal of the National Medical Association 2012;104(1-2):53-60.
2011: Fadia T. Shaya; Viktor V Chirikov
Decision support tools to optimize economic outcomes for type 2 diabetes.
The American journal of managed care 2011;17 Suppl 14():S377-83.
2011: Wallace R Johnson Jr; Niharika Khanna; C. Daniel Mullins; Vivienne A Rose; Fadia T. Shaya; Verlyn O Warrington; Xia Yan; Bessie Bailey-Weaver; Elijah Saunders
The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(8):563-70.
2011: Eberechukwu Onukwugha; C. Daniel Mullins; F Ellen Loh; Elijah Saunders; Fadia T. Shaya; Matthew R Weir
Readmissions after unauthorized discharges in the cardiovascular setting.
Medical care 2011;49(2):215-24.
2011: Fadia T. Shaya; Reed Winston; Confidence M Gbarayor; Aurelia Laird; Elijah Saunders
Diabetes knowledge in a high risk urban population.
Ethnicity & disease 2011;21(4):485-9.
2011: Nneka C Onwudiwe; C. Daniel Mullins; Reed A Winston; Fadia T. Shaya; Françoise Pradel; Aurelia Laird; Elijah Saunders
Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics.
Ethnicity & disease 2011;21(1):27-32.
2010: Fadia T. Shaya; Xia Yan; Maryam Farshid; Samer Barakat; Miah Jung; Sara Low; Donald O. Fedder
Social networks in cardiovascular disease management.
Expert review of pharmacoeconomics & outcomes research 2010;10(6):701-5.
2010: Fadia T. Shaya; Xia Yan; Pei-Jung Lin; Linda Jean Simoni-Wastila; Morgan Bron; Robert Baran; Thomas W Donner
US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2010;12(10):826-32.
2010: Ashley Bivins; Karolyn Hou; Nana Ayesu; Brian Ellsworth; Susan Montenegro; Xiao Tu; Cynthia J. Boyle; Thomas C. Dowling; Fadia T. Shaya
Clinical evaluation of natalizumab for formulary consideration.
Expert opinion on biological therapy 2010;10(8):1279-87.
2010: David W Brandes; Fadia T. Shaya; Michael W Pill
Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.
The American journal of managed care 2010;16(6 Suppl):S171-7.
2010: Pei-Jung Lin; Fadia T. Shaya; Steven M Scharf
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
Respiratory medicine 2010;104(5):697-704.
2010: Justin Bakhshai; Raymond Bleu-Lainé; Miah Jung; Jeanne Lim; Christian Reyes; Linda Sun; Charmaine D Rochester; Fadia T. Shaya
The cost effectiveness and budget impact of natalizumab for formulary inclusion.
Journal of medical economics 2010;13(1):63-9.
2009: Fadia T. Shaya; Pei-Jung Lin; Mohammad H Aljawadi; Steven M Scharf
Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome.
Sleep & breathing = Schlaf & Atmung 2009;13(4):317-23.
2009: Fadia T. Shaya; Sara Low; Sameh Barakat; Maryam Farshid; Miah Jung; Nicole Norman; Donald O. Fedder
Case for a pharmacy-centered medical home.
Expert review of pharmacoeconomics & outcomes research 2009;9(5):397-9.
2009: Fadia T. Shaya; Zhiqiang Lu; Kyongsei Sohn; Matthew R Weir
Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.
P & T : a peer-reviewed journal for formulary management 2009;34(9):490-501.
2009: Fadia T. Shaya; Mark S Maneval; Confidence M Gbarayor; Kyongsei Sohn; Anand A Dalal; Dongyi Du; Steven M Scharf
Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population.
Chest 2009;136(2):405-11.
2009: Betina T Blak; C. Daniel Mullins; Fadia T. Shaya; Linda Jean Simoni-Wastila; Catherine E Cooke; Matthew R Weir
Prescribing trends and drug budget impact of the ARBs in the UK.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(2):302-8.
2009: Christopher M Blanchette; Linda Jean Simoni-Wastila; Fadia T. Shaya; Denise Orwig; Jason M. Noel; Bruce Stuart
Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2009;66(4):366-72.
2009: Christopher M Blanchette; Linda Jean Simoni-Wastila; Fadia T. Shaya; Denise Orwig; Jason M. Noel; Bruce Stuart
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.
Cardiology research and practice 2009;2009():194528.
2009: Eberechukwu Onukwugha; Fadia T. Shaya; Elijah Saunders; Matthew R Weir
Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease.
Ethnicity & disease 2009;19(2):172-8.
2009: Fadia T. Shaya; Dongyi Du; Confidence M Gbarayor; Feride Frech-Tamas; Helen Lau; Matthew R Weir
Predictors of compliance with antihypertensive therapy in a high-risk medicaid population.
Journal of the National Medical Association 2009;101(1):34-9.
2008: Fadia T. Shaya; Dongyi Du; Feride Frech-Tamas; Helen Lau; Hugh Fatodu; Howard Garber
Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population.
Journal of the American Society of Hypertension : JASH 2008;2(6):469-75.
2008: Teisha A Robertson; Catherine E Cooke; Jingshu Wang; Fadia T. Shaya; Helen Y Lee
Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
The American journal of managed care 2008;14(11):710-6.
2008: Fadia T. Shaya; Du Dongyi; Manabu O Akazawa; Christopher M Blanchette; Jingshu Wang; Douglas W Mapel; Anand Dalal; Steven M Scharf
Burden of concomitant asthma and COPD in a Medicaid population.
Chest 2008;134(1):14-9.
2008: Fadia T. Shaya; Anna Gu; Xia Yan
Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.
P & T : a peer-reviewed journal for formulary management 2008;33(5):288-95.
2008: Fadia T. Shaya; David Flores; Confidence M Gbarayor; Jingshu Wang
School-based obesity interventions: a literature review.
The Journal of school health 2008;78(4):189-96.
2008: Sunanda Kane; Fadia T. Shaya
Medication non-adherence is associated with increased medical health care costs.
Digestive diseases and sciences 2008;53(4):1020-4.
2007: Fadia T. Shaya; Mohammad Aljawadi
Diabetic retinopathy.
Clinical ophthalmology (Auckland, N.Z.) 2007;1(3):259-65.
2007: Junling Wang; Ilene Harris Zuckerman; Nancy A Miller; Fadia T. Shaya; Jason M. Noel; C. Daniel Mullins
Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.
Health services research 2007;42(4):1499-519.
2007: Jingshu Wang; C. Daniel Mullins; Muhammad Mamdani; Dale Rublee; Fadia T. Shaya
New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study.
The Annals of pharmacotherapy 2007;41(6):937-43.
2007: Fadia T. Shaya; Navendu Samant; Françoise Pradel; C. Daniel Mullins; Steven M Scharf; James Britt
Health-related quality of life as a potential predictor in chronic obstructive lung disease patients.
Expert review of pharmacoeconomics & outcomes research 2007;7(2):129-35.
2007: Fadia T. Shaya; Confidence M Gbarayor; Marriette Agyeman-Duah; Elijah Saunders
A perspective on African American participation in clinical trials.
Contemporary clinical trials 2007;28(2):213-7.
2007: Fadia T. Shaya; Robert L Ohsfeldt
Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy.
Journal of managed care pharmacy : JMCP 2007;13(1):66-7.
2006: Fadia T. Shaya; Confidence M Gbarayor
The case for cultural competence in health professions education.
American journal of pharmaceutical education 2006;70(6):124.
2006: Junling Wang; Jason M. Noel; Ilene Harris Zuckerman; Nancy A Miller; Fadia T. Shaya; C. Daniel Mullins
Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.
Medical care research and review : MCRR 2006;63(6):742-63.
2006: C. Daniel Mullins; Andreas Kuznik; Fadia T. Shaya; Nour A Obeidat; Andrew R Levine; Larry Z Liu; Winston Wong
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Clinical therapeutics 2006;28(8):1184-98.
2006: Fadia T. Shaya; Kareem E Shaya
Medication access in the Middle East.
Lancet 2006;367(9525):1818.
2006: Fadia T. Shaya; Antoine C El Khoury; C. Daniel Mullins; Dongyi Du; Richard L Skolasky; Hugh Fatodu; Howard Garber; Matthew R Weir
Drug therapy persistence and stroke recurrence.
The American journal of managed care 2006;12(6):313-9.
2006: Fadia T. Shaya; Gaurav Deshpande
New treatment approaches to diabetes.
Managed care (Langhorne, Pa.) 2006;15(5):38, 40-1.
2006: Fadia T. Shaya; Confidence Gbarayor
Adjusting for risk and confounding in outcomes research.
Expert review of pharmacoeconomics & outcomes research 2006;6(2):109-10.
2006: C. Daniel Mullins; Fadia T. Shaya; Julie M. Zito; Nour A Obeidat; John Naradzay; David J Harrison
Effect of initial ziprasidone dose on treatment persistence in schizophrenia.
Schizophrenia research 2006;83(2-3):277-84.
2006: Fadia T. Shaya; Anna Gu
Deriving effectiveness information for decision-making.
Expert review of pharmacoeconomics & outcomes research 2006;6(1):5-7.
2006: C. Daniel Mullins; Fadia T. Shaya; Fanlun Meng; Junling Wang; Morgan S Bron
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
Clinical therapeutics 2006;28(2):297-305; discussion 296.
2006: Fadia T. Shaya; Anna Gu; Elijah Saunders
Addressing cardiovascular disparities through community interventions.
Ethnicity & disease 2006;16(1):138-44.
2005: Fadia T. Shaya
Compliance with medicine.
Ophthalmology clinics of North America 2005;18(4):611-7.
2005: Fadia T. Shaya; Navendu Samant; Richard L Skolasky; Elijah Saunders
Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores.
Expert review of pharmacoeconomics & outcomes research 2005;5(5):625-32.
2005: Fadia T. Shaya
The burden of obstructive lung disease in Medicaid and managed care populations.
Managed care (Langhorne, Pa.) 2005;14(7 Suppl Obstructie Lung):20-3; discussion 24-6.
2005: Fadia T. Shaya; Steven Blume; Anna Gu; Teresa Zyczynski; Zhanna Jumadilova
Persistence with overactive bladder pharmacotherapy in a Medicaid population.
The American journal of managed care 2005;11(4 Suppl):S121-9.
2005: Fadia T. Shaya; winslow klaskala; C. Daniel Mullins
Review of cost-effectiveness studies of pegylated therapies for hepatitis C.
Expert review of pharmacoeconomics & outcomes research 2005;5(3):339-51.
2005: Fadia T. Shaya; Antoine C El Khoury
Developing benchmarks for adherence studies.
Expert review of pharmacoeconomics & outcomes research 2005;5(3):229-32.
2005: Fadia T. Shaya; Anna Gu
Assessing potential risks and evaluating expected benefits.
Managed care interface 2005;18(5):27-30.
2005: C. Daniel Mullins; Fadia T. Shaya; Fanlun Meng; Junling Wang; David Harrison
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Pharmacotherapy 2005;25(5):660-7.
2005: Fadia T. Shaya; James Y Shin; C. Daniel Mullins; Hugh Fatodu; Anna Gu; Elijah Saunders
Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.
Journal of the National Medical Association 2005;97(4):493-7.
2005: Fadia T. Shaya; Steven Blume; Christopher M Blanchette; Matthew R Weir; C. Daniel Mullins
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.
Archives of internal medicine 2005;165(2):181-6.
2005: Fadia T. Shaya; Steven Blume
Prescriptions for cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory agents in a medicaid managed care population: African Americans versus Caucasians.
Pain medicine (Malden, Mass.) 2005;6(1):11-7.
2004: Fadia T. Shaya; Navendu Samant
Formulary decision methodology in the context of health system costs and insurance trends.
Expert review of pharmacoeconomics & outcomes research 2004;4(6):595-7.
2004: Fadia T. Shaya; Navendu Samant
Cost studies in clinical trials.
Expert review of pharmacoeconomics & outcomes research 2004;4(6):591-4.
2004: Fadia T. Shaya; Winston Wong; James Y Shin; LeeAnn Martin; Navendu Samant
Formulary decision-making considerations: COX-2 inhibitors.
Managed care interface 2004;17(11):29-36, 41.
2004: Fadia T. Shaya; Steven Blume; C. Daniel Mullins
Prescription drug spending trends for the privately insured in Maryland, 2000-2001.
Health affairs (Project Hope) 2004;23(5):226-32.
2004: Fadia T. Shaya; James Y Shin; Winston I Wong; Woodrow Proveaux
Clinical and economic evaluation of gatifloxacin and levofloxacin.
Expert review of pharmacoeconomics & outcomes research 2004;4(4):469-77.
2004: C. Daniel Mullins; Jesse L Cooke; Junling Wang; Fadia T. Shaya; Doren Van Hsu; Sandra E Brooks
Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid.
Journal of the National Medical Association 2004;96(6):809-16.
2004: C. Daniel Mullins; Fadia T. Shaya; Louis R Flowers; Elijah Saunders; Wallace R Johnson Jr; Winston Wong
Health care cost of analgesic use in hypertensive patients.
Clinical therapeutics 2004;26(2):285-93.
2003: C. Daniel Mullins; Elizabeth M Ndiritu; David M Yoder; Fadia T. Shaya; Teisha A Taylor
Impact of the fourth hurdle on the international pharmaceutical industry.
Expert review of pharmacoeconomics & outcomes research 2003;3(2):169-77.
2003: Fadia T. Shaya
Summary quality scores for pharmacoeconomic studies: balancing validity with need.
Journal of managed care pharmacy : JMCP 2003;9(1):87-8.
2002: Fadia T. Shaya; C. Daniel Mullins; Winston Wong
Incidence versus prevalence modeling in pharmacoeconomics.
Expert review of pharmacoeconomics & outcomes research 2002;2(5):435-42.
2002: Fadia T. Shaya; C. Daniel Mullins; Winston Wong; Jeannie Cho
Discontinuation rates of topical glaucoma medications in a managed care population.
The American journal of managed care 2002;8(10 Suppl):S271-7.